Literature DB >> 21044668

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.

Michael J McConnell1, Jerónimo Pachón.   

Abstract

The treatment of infections caused by Acinetobacter baumannii has become increasingly complicated due to the emergence of highly resistant strains. In the present study we demonstrate that immunization with an inactivated whole cell vaccine elicits a robust antibody response that provides protection against challenge with multiple A. baumannii strains in a murine model of disseminated sepsis. In addition, we show that passive immunization with serum raised against inactivated cells protects mice from subsequent infection. These results demonstrate that active and passive immunization using an inactivated whole cell vaccine may be an effective approach for preventing infection by A. baumannii.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044668     DOI: 10.1016/j.vaccine.2010.10.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Healthcare-associated infections: potential for prevention through vaccination.

Authors:  E David G McIntosh
Journal:  Ther Adv Vaccines Immunother       Date:  2018-03-14

3.  Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity.

Authors:  Federica Runci; Valentina Gentile; Emanuela Frangipani; Giordano Rampioni; Livia Leoni; Massimiliano Lucidi; Daniela Visaggio; Greg Harris; Wangxue Chen; Julia Stahl; Beate Averhoff; Paolo Visca
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

4.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

6.  Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.

Authors:  Sarah Ainsworth; Patrick M Ketter; Jieh-Juen Yu; Rose C Grimm; Holly C May; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2017-05-15       Impact factor: 3.641

Review 7.  New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections.

Authors:  Burcu Isler; Yohei Doi; Robert A Bonomo; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

8.  Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.

Authors:  Travis B Nielsen; Paul Pantapalangkoor; Brian M Luna; Kevin W Bruhn; Jun Yan; Ken Dekitani; Sarah Hsieh; Brandon Yeshoua; Bryan Pascual; Evgeny Vinogradov; Kristine M Hujer; T Nicholas Domitrovic; Robert A Bonomo; Thomas A Russo; Magda Lesczcyniecka; Thomas Schneider; Brad Spellberg
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

9.  Identification of antigens from nosocomial Acinetobacter baumannii clinical isolates in sera from ICU staff and infected patients using the antigenome technique.

Authors:  Tina Nafarieh; Mojgan Bandehpour; Ali Hashemi; Sodabeh Taheri; Vahid Yardel; Hamidreza Jamaati; Seyed Mahdi Moosavi; Nariman Mosaffa
Journal:  World J Microbiol Biotechnol       Date:  2017-09-30       Impact factor: 3.312

10.  Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Authors:  Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Beverlie Baquir; Andrew Tomaras; Justin I Montgomery; Usa Reilly; Elsa G Barbacci; Kristine Hujer; Robert A Bonomo; Lucia Fernandez; Robert E W Hancock; Mark D Adams; Samuel W French; Virgil S Buslon; Brad Spellberg
Journal:  MBio       Date:  2012-10-02       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.